Aller au contenu
Institut Servier
EN
Symposium team
Symposium

Colloque Neuro-Immuno-Oncology

Le colloque international de L’Institut Servier a eu lieu à Paris, site Neker, le 20 septembre 2024 et était dédié à la Neuro-Immuno-Oncologie. Le programme scientifique élaboré par les Pr G. Kroemer (Université Paris Cité) et E. Tartour (HEGP) a réuni près de 15 Experts, Chercheurs, Cliniciens venus du monde entier.

Lieu : Université Paris Cité - Site Necker - Amphithéâtre 2

Adresse : 160, rue de Vaugirard, 75015 Paris, France

Événements scientifiques passés

–

Session 1 – Overview of the topic

  • Sophie Ugolini
  • Guido Kroemer
–

Presentation of the symposium

  • Guido Kroemer, Centre de Recherche des Cordeliers, Metabolism Laboratory Cancer and Immunity, Iserm, Université Paris Cité
–

Keynote lecture – Innovative therapeutic multi-targeting of the TME to unlock anti-tumor immunity in glioblastoma

  • Douglas Hanahan, Ludwig Institute for Cancer Research, Swiss Institute for Esperimental – Cancer Research (ISREC), Lausanne
–

Neuronal regulation of immunity: new pathways and therapeutic perspectives

Neuronal regulation of immunity: new pathways and therapeutic perspectives
  • Sophie Ugolini, Immunology Center of Marseille-Luminy, Marseille
–

Pathogenic mechanisms in CNS inflammatory diseases and their therapeutic targeting

Pathogenic mechanisms in CNS inflammatory diseases and their therapeutic targeting
  • Roland Liblau, Immunology Laboratory, CHU Purpan, Toulouse
–

Session 2 – Neurotransmitters affecting immuno-oncology

  • Claire Magnon
  • Stéphane de Botton, Institut Gustave Roussy, Villejuif
–

The neural environment of cancer

  • Claire Magnon, Laboratory of Cancer and Microenvironment, Inserm, Université Paris Descartes
–

Pain neurons control cancer immunosurveillance

Pain neurons control cancer immunosurveillance
  • Sébastien Talbot, Department of Biomedical and Molecular Sciences, Qeen's University, Ontario
–

Secreted neuro-immune-metabolites mediating anti-tumor responses

Secreted neuro-immune-metabolites mediating anti-tumor responses
  • Sidonia Fagarasan, Laboratory for Mucosal Immunity, RIKEN Center, Kyoto University
–

Session 3 – Immuno-oncology-of brains tumors

  • François Doz, Institut Curie
  • Stéphane Oudard, Hôpital Européen Georges Pompidou, Paris
–

Targeting T cells to brain tumors

Targeting T cells to brain tumors
  • Michael Platten, German Cancer Research Center, Heidelberg University
–

Session 4 – Neuroendocrine stress in immuno-oncology

  • Kristin Astlid Tasken
  • Eric Tartour, Hôpital Européen Georges Pompidou, Paris
–

Can we prevent postoperative metastases in cancer patients? Perioperative inhibition of adrenergic and prostaglandin signaling through repurposed drugs

Can we prevent postoperative metastases in cancer patients? Perioperative inhibition of adrenergic and prostaglandin signaling through repurposed drugs
  • Shamgar Ben-Eliyahu, Neuroimmunology Research Laboratory, Tel Aviv University
–

Targeting sympathetic nerve signaling in prostate cancer

Targeting sympathetic nerve signaling in prostate cancer
  • Kristin Astlid Tasken, Institute of Cancer Research, Oslo University Hospital
–

Neuroendocrine regulation of the anticancer immune response

  • Guido Kroemer
–

General discussion and conclusion

What about the next decade?

  • Guido Kroemer
  • Eric Tartour
Découvrez le programme